Kobo Biotech Limited

KOBO

INE881A01015

Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 11:00:56 28/06/2024 BST			5-day change	1st Jan Change
3.8 ^INR	-4.52%		-9.95%	+22.58%

07:46am	Kobo Biotech Limited Announces Resignation of Jignesh Patel as Company Secretary and Compliance Officer	CI
05-30	Kobo Biotech Limited Announces Resignation of Abhishek Buddhadev as Non-Executive and Independent Director	CI

Kobo Biotech Limited Announces Change in Registered Office Address

August 12, 2022 at 07:11 am

Kobo Biotech Limited informed that with effect from 11 August, 2022, the Registered Office of the Company will be at Plot No. 121A11, Western Hills, Addagutta Society, Opp. JNTU, Kukatpally, Hyderabad - 500072, Telangana.

Latest news about Kobo Biotech Limited

Kobo Biotech Limited Announces Resignation of Jignesh Patel as Company Secretary and Compliance Officer	06:46am	CI
Kobo Biotech Limited Announces Resignation of Abhishek Buddhadev as Non-Executive and Independent Director	05-30	CI
Kobo Biotech Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	05-30	CI
Kobo Biotech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	02-14	CI
Kobo Biotech Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	11-10	CI
Kobo Biotech Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	11/08/23	CI
Kobo Biotech Limited Reports Earnings Results for the Full Year Ended March 31, 2023	30/05/23	CI
Kobo Biotech Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023	30/05/23	CI
Kobo Biotech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	13/02/23	CI
Kobo Biotech Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	14/11/22	CI
Kobo Biotech Limited Announces Change in Registered Office Address	12/08/22	CI
Kobo Biotech Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	11/08/22	CI
Kobo Biotech Limited Reports Earnings Results for the Full Year Ended March 31, 2022	30/05/22	CI
Kobo Biotech Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2022	30/05/22	CI
Kobo Biotech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021	14/02/22	CI
Kobo Biotech Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021	08/11/21	CI
Kobo Biotech Limited Reports Earnings Results for the First Quarter Ended June 30, 2021	13/08/21	CI
Kobo Biotech Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2021	30/06/21	CI
Kobo Biotech Limited Reports Earnings Results for the Third Quarter Ended December 31, 2020	12/02/21	CI
Kobo Biotech Limited Reports Earnings Results for the Second Quarter Ended September 30, 2020	13/11/20	CI
Avon Lifesciences Limited Reports Earnings Results for the First Quarter Ended June 30, 2020	15/09/20	CI
Avon Lifesciences Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2020	30/06/20	CI
Avon Lifesciences Limited Reports Earnings Results for the Third Quarter Ended December 31, 2019	14/02/20	CI
Avon Lifesciences Limited Reports Earnings Results for the Second Quarter Ended September 30, 2019	14/11/19	CI
Avon Lifesciences Limited Changes Registered Office Address	09/10/19	CI

Chart Kobo Biotech Limited

Duration

Period

More charts

Company Profile

Kobo Biotech Limited is an India-based company. The Company's business segment is manufacturing active pharmaceutical ingredients (APIs)/bulk drugs. The Company has no operational activities being carried out at its Solapur site, India.

Sector

Pharmaceuticals

Calendar

08/08/2024 - Q1 2025 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
KOBO BIOTECH LIMITED	+22.58%	1.14M
ELI LILLY AND COMPANY	+56.59%	819B
JOHNSON & JOHNSON	-6.42%	351B
MERCK & CO., INC.	+18.40%	329B
ABBVIE INC.	+9.49%	298B
ASTRAZENECA PLC	+16.57%	242B
ROCHE HOLDING AG	+2.04%	225B
NOVARTIS AG	+13.31%	217B
AMGEN INC.	+8.49%	168B
PFIZER, INC.	-3.06%	158B